Latest news with #ManagementSolutions
Yahoo
06-05-2025
- Business
- Yahoo
WTW integrates Moody's flood data into risk management tools
Willis Towers Watson (WTW) has integrated Moody's global flood data into its risk management tools. This builds upon Moody's existing partnership with WTW, which has previously integrated catastrophe models into its Property Quantified platform. WTW stated that with this move, its clients can gain access to additional insights to optimise insurance programmes and risk management strategies. WTW core analytics global head Ben Fidlow said: 'We will continue to invest in technology, data and partnerships for the benefit of our clients. 'Expanding the use of Moody's analytics across a broader range of perils gives our clients better decision support on how to mitigate and transfer loss potential. This is not a static deliverable, our clients can access Property Quantified directly through our Risk Intelligence Quantified platform, empowering the ownership of risk analysis at the insurance buyer level.' Moody's insurance sales global head Mike Richitelli stated: 'Moody's is fully committed to continued investment into data, analytics, models and software that empower the entire risk and insurance value chain to conduct business in more streamlined, efficient and valuable ways. 'This new engagement with Willis demonstrates how our respective technology platforms can integrate to bring tools and valuable insights to risk and insurance decision makers.' Moody's assists a variety of sectors including the insurance and financial services industries, as well as the public sector, with its Risk Management Solutions models. These models evaluate risks associated with natural and man-made disasters including floods, earthquakes and pandemics. This March, WTW broadened its partnership with the Karlsruhe Institute of Technology. This effort, in conjunction with NASA's Disasters Programme and the NASA Langley Research Centre, aims to advance the understanding of hailstorm risks in Europe. "WTW integrates Moody's flood data into risk management tools " was originally created and published by Life Insurance International, a GlobalData owned brand.
BBC News
25-03-2025
- Business
- BBC News
Bid for Douglas Promenade food and drink market for TT
Plans have been put forward for a temporary promenade food and drink market to "liven up" an area of the Isle of Man's capital during the 2025 TT Management Solutions has applied for permission to hold a marketplace at the Bottleneck Car Park at the southern end of the Douglas site was previously home to the Bushy's Beer Tent for 20 years, which moved to the Villa Marina gardens in approved, the site would include a main covered bar area, food and drink vans showcasing local offerings, and portable toilets. Operations Manager Andrew Saunders said the event management firm aimed to "create a lively environment" where people could try local Manx produce. The company hopes to run the pop-up on the plot from 21 May until 8 June during the TT motorcycling festival. Mr Saunders said it would be a "nice new environment to liven up that end of the promenade" where there had been "reduced footfall".It would also give Manx companies an opportunity to showcase produce to both visitors and locals, he added. Read more stories from the Isle of Man on the BBC, watch BBC North West Tonight on BBC iPlayer and follow BBC Isle of Man on Facebook and X.
Yahoo
20-03-2025
- Business
- Yahoo
Pulsed Field Ablation Market to Hit USD 2,127.9 Million by 2032, Exhibiting a 38.90% CAGR
According to Research by SNS Insider, The Pulsed Field Ablation Market Growth is Driven by Technological Advancements and Rising Prevalence of Atrial Fibrillation Pune, March 20, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Pulsed Field Ablation Market size was valued at USD 110.8 million in 2023 and is expected to reach USD 2127.9 million by 2032, growing at a remarkable CAGR of 38.90% from 2024 to 2032. The increasing prevalence of atrial fibrillation (AF), coupled with technological advancements in minimally invasive cardiac procedures, is driving the demand for pulsed field ablation (PFA) systems a Sample Report of Pulsed Field Ablation Market@ Market analysis Pulsed Field Ablation is a new non-thermal ablation technique that improves treatment precision and efficiency for cardiac arrhythmias, especially for atrial fibrillation. PFA enables selective cardiac tissue ablation with high-energy electric fields without employing classical thermal ablation which causes collateral damage and prolonged procedure durations. This latest method is playing its role in driving a change in the way patients with arrhythmias are being treated helping achieve better results while also allowing them to be discharged sooner. One of the key factors driving the PFA market is the growing incidence of atrial fibrillation. Estimates by the Centers for Disease Control and Prevention (CDC) suggest the number of people in the U.S. with AF will reach 12.1 million by 2030. AF increases the risk of stroke, heart failure, and other cardiovascular complications, highlighting the need for effective treatment options, such as PFA. Market growth is further driven by technological advancements in ablation devices including enhanced multi-electrode catheters, and technology-integrated mapping systems. In addition, increasing awareness among healthcare professionals regarding better outcomes associated with PFA such as lower complications during procedure and higher precision will further contribute to the market expansion. Key Pulsed Field Ablation Companies Profiled Medtronic - (PFA System, Cryoablation Catheters) Boston Scientific - (Pulsed Field Ablation Catheter, Rhythm Management Solutions) Abbott (TactiCath - Contact Force Ablation Catheter, EP Mapping System) Philips Healthcare - (Ultrasound Systems, EP Navigation Solutions) Johnson & Johnson - (Biosense Webster™ EP System, ThermoCool™ SmartTouch Catheter) AtriCure - (AtriClip™ Left Atrial Appendage Exclusion Device, Isolator Synergy Ablation System) Siemens Healthineers - (ARTIS pheno™, Acuson Sequoia Ultrasound) Stereotaxis - (Niobe ES Magnetic Navigation System, Stereotaxis Odyssey) Hansen Medical - (Magellan Robotic Catheter System, Sensei X Robotic Catheter System) MediGuide - (MediGuide™ System for Catheter Navigation, MediGuide Solutions) iRhythm Technologies - (Zio Patch, Zio Service Platform) LivaNova - (VNS Therapy System, Perioperative Monitoring Solutions) Endologix - (Aortic Intervention Devices, Endovascular Solutions) Cardinal Health - (Interventional Catheters, Ablation Services) Biotronik - (Eclipse Pacing Lead, Novacor Implantable System) St. Jude Medical - (Amigo Remote Catheter System, Ensite Velocity System) Inari Medical - (ClotTriever Device, FlowTriever Device) Merit Medical Systems - (EmboGuide Catheter, Merit Vascular Access Products) Bard Medical - (Ablation Devices, Peripheral Vascular Access Products) ConMed - (Ablation System, Electrosurgical Products) Pulsed Field Ablation Market Report Scope Report Attributes Details Market Size in 2023 US$ 110.8 million Market Size by 2032 US$ 2,127.9 million CAGR CAGR of 38.90% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Key Regional Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) Segment Analysis By Component The catheter segment led the Pulsed Field Ablation (PFA) market in 2023, with a revenue share of 89.3%. PFA procedures are primarily performed by catheters that deliver pulsed electric fields to targeted cardiac tissue to treat arrhythmia. Newer catheters adopted improved design features, including flexible tips, and multi-electrode configurations, and integrated with advanced mapping systems to enhance their accuracy and safety. The new technology enables a more efficient delivery of energy, thereby reducing procedural times and limiting the potential for complications. In addition, the use of biocompatible materials and improved durability have contributed to the increased longevity of catheters, making them more cost-effective. Additionally, supporting devices such as generators, which ensure accurate energy delivery, and mapping systems, which enable real-time monitoring of the ablation process, complement the ablation catheters. The catheter segment is anticipated to maintain its dominance due to the focus of manufacturers on designing next-generation devices that offer better function and positive patient outcomes. By Indication In 2023, the atrial fibrillation (AF) segment accounted for the largest 97.2% market share owing to the high prevalence of AF in the world. Atrial fibrillation is the commonest cardiac arrhythmia observed in millions of people with an increase in the elderly population. Finally, PFA has the important property that it selectively ablates myocardial tissue without causing thermal damage to the surrounding structures, and thus, it is a highly promising therapy for AF. The segment's growth can be attributed to both the rising geriatric population, which is more prone to suffering from AF, and its related complications (such as stroke and heart failure). Other indications, such as ventricular tachycardia and supraventricular tachycardia, are also benefiting from PFA technology but have a smaller market share. With the improved detection capability in more complex arrhythmias, PFA systems would have the potential to treat an increased array of arrhythmia types, which may further drive market growth and applications of PFA systems as they become increasingly more developed and accessible. By End-Use The market share of the inpatient facilities segment was 90.8% by revenue in 2023. Given the requirement for sophisticated infrastructure, astute personnel, and holistic post-procedure care, the PFA procedures are predominantly performed in inpatient settings, usually hospitals or specialized cardiac centers. They are outfitted with advanced monitoring systems and emergency response equipment to provide secure patient transport to and from both inpatient and outpatient ablation procedures. The segment predominance is also due to a high number of complex cardiac cases treated by the hospitals. However, the increasing trend towards performing cardiac procedures on an outpatient basis, particularly in North America and Europe, is expected to be one of the factors contributing to the growth of PFA in ambulatory surgical centers (ASCs). The movement toward outpatient care is driven by improved recovery times, more effective minimally invasive techniques, and cost-effective procedures, making PFA an ideal candidate for ASCs. Need Any Customization Research on Pulsed Field Ablation Market, Enquire Now@ Pulsed Field Ablation Market Segmentation By Component Catheters Generators By Indication Atrial Fibrillation Non-atrial Fibrillation By End-Use Inpatient Facilities Outpatient Facilities Regional Analysis North America held the largest share of the PFA market in 2023, with the high prevalence of atrial fibrillation, the presence of well-established healthcare infrastructure, and strong government support for cardiac care driving the growth of this market. The U.S. is a key contributor, with the CDC reporting that AF affects approximately 2.7–6.1 million Americans. These include the presence of leading market players, including Medtronic and Boston Scientific, as well as the growing investments toward R&D for next-generation ablation technologies, thus driving regional market growth. Moreover, favourable reimbursement policies and increasing knowledge about the advantages of PFA among healthcare professionals is fuelling its adoption. The global PFA market will also continue to be led by the North America region because of the presence of several clinical trial and technological development services. Due to better healthcare infrastructure, increasing healthcare expenditure, and high awareness regarding cardiac arrhythmias, the Asia-Pacific region is expected to be the fastest-growing market during the forecast period. Countries such as China, India, and Japan are making significant investments to modernize their healthcare systems and are emphasizing minimizing the burden of CVD. For instance, NPCDCS (National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke) launched by the Indian government is encouraging the adoption of advanced treatments, such as PFA. The region being home to a vast patient population and increasing adoption of minimally invasive processes are some of the growth opportunities. Approximately 65% of the world's population is currently found in the Asia-Pacific region, and as PFA technology becomes more affordable and available in the country, the adoption of PFA technology in Asia-Pacific will grow, making it a high-growth market. Recent Developments Medtronic company had launched its PulseSelect™ PFA System and announced receiving CE Mark approval in 2023 for the treatment of atrial fibrillation. It is capable of providing accurate and effective ablation with very low complication rates. In January 2024, Boston Scientific announced that its FARAPULSE™ PFA System which combines a flexible catheter and built-in mapping features to improve procedure accuracy received FDA a Single-User PDF of Pulsed Field Ablation Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Pulsed Field Ablation Market by Component 8. Pulsed Field Ablation Market by Indication 9. Pulsed Field Ablation Market by End-Use 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion Access Complete Report Details of Pulsed Field Ablation Market Analysis & Outlook 2024-2032@ [For more information or need any customization research mail us at info@ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)Sign in to access your portfolio
